62836
  • Log in
The Daily Sceptic
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter
The Daily Sceptic
No Result
View All Result

PHE Quietly Revises Down Effectiveness of AstraZeneca Vaccine

by Will Jones
2 June 2021 12:21 AM

The latest Public Health England (PHE) weekly vaccine surveillance report appeared on Thursday (another one is due tomorrow).

I wasn’t holding out high hopes for this instalment, after digging down into the method used the previous week and finding it didn’t control adequately for background incidence (so confounded vaccine effectiveness with natural decline) and applied such brutal adjustments it could turn a 4% effectiveness into a 73% one. It lived down to expectations.

The authors appear still to be working out what exactly their reports are for as each of the three to date presents different information in a slightly different way. While the first was largely a summary of evidence published elsewhere, the second served more as a showcase for PHE’s latest study and focused on effectiveness against symptomatic disease in the over-65s (90%, supposedly). This week, the over-65s are gone and the focus is on effectiveness against the Indian variant. This makes reading the reports quite confusing, as each doesn’t feel so much like an update to the previous one as a stand-alone report on a separate topic.

In between Report 2 (for week 20) and Report 3, a separate PHE study was published on the Indian Delta variant which found the effectiveness of full vaccination against symptomatic Covid reduced from 93% to 88% with Pfizer and 66% to 60% with AstraZeneca when the Indian Delta variant was involved versus the British Alpha variant.

As I noted last week, this 66% effectiveness of AstraZeneca (against the British Alpha variant) was a long way below the 90% in the over-65s claimed in Report 2. It’s probably a sign of how low my opinion is of PHE vaccine studies that I was pleasantly surprised to see this discrepancy actually make an impact on the data presented in Report 3, and you can see below in the AstraZeneca two-doses box (top right) week 20’s “85-90%” has become “65% to 90%” in week 21. There is still no explanation from PHE, however, as to why one of their studies finds AstraZeneca 90% effective against symptomatic infection in the over-65s while another finds it is just 66% effective in all ages. Is this not the kind of discrepancy that should occasion comment from the authors?

Week 20 (identical to Week 19 except with the addition of a figure for AZ two doses)
Week 21 (Report 3)

Another moment where full transparency seems to be lacking is in the section about the Indian Delta variant, where rather than presenting the figures for each vaccine separately the authors combine the data for the two vaccines to give 81% overall effectiveness against the new variant.

This seems a strange decision given that this breaks down to 88% for Pfizer and 60% for AstraZeneca, making Pfizer almost 50% more effective than AstraZeneca against the Indian Delta variant. Was this done to spare AstraZeneca’s blushes? Certainly there’s no sign of PHE drawing attention to this disappointing AZ data. We might wonder though: is part of what is driving the recent fear-mongering from SAGE scientists a worry that the Oxford “workhorse” vaccine is not up to the job, particularly in the most vulnerable?

Another oddity is that the report states that “by May 23rd 2021, the overall vaccine uptake in England for dose 1 was 51.3% and 31.4% for dose 2”. Yet the Government dashboard shows 72% of the adult population had one dose and 42% had two doses by that date. The reason? The report is counting children in the unvaccinated population, but without noting this fact.

Overall my feeling is that these reports have been of limited usefulness (so far), and manage to confuse as often as they clarify. What we really need from PHE are studies which control properly for background incidence so we can get a proper picture of how effective the vaccines actually are, including in the frail elderly where many of the deaths are concentrated. We are also waiting for a proper analysis of the post-vaccination infection spike, rather than half-baked attempts to explain it away, and are long overdue studies that include analysis of safety and not just efficacy. Will PHE step up to the plate?

Tags: AstraZenecaIndian variantPHEVaccine efficacyVaccines

Donate

We depend on your donations to keep this site going. Please give what you can.

Donate Today

Comment on this Article

You’ll need to set up an account to comment if you don’t already have one. We ask for a minimum donation of £5 if you'd like to make a comment or post in our Forums.

Sign Up
Previous Post

Zero Daily Deaths Announced In the Whole Of the U.K. for First Time

Next Post

News Round-Up

Subscribe
Login
Notify of
Please log in to comment

Profanity and abuse will be removed and may lead to a permanent ban.

21 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

NEWSLETTER

View today’s newsletter

To receive our latest news in the form of a daily email, enter your details here:

 

DONATE

PODCAST

Nick Dixon and Toby Young Talk About Trump’s Arrest, the Police’s Preference for Wokery Over Free Speech and the Glorious Implosion of the SNP

by Will Jones
21 March 2023
2

LISTED ARTICLES

  • Most Read
  • Most Commented
  • Editors Picks

40% of Brits Still Wearing Masks and Taking Covid Tests as Experts Call for New Mask Mandate Amid Rise in Infections

23 March 2023
by Will Jones

News Round-Up

23 March 2023
by Will Jones
sheepsinmasks.jpg

Is There No Cure For Maskaholics?

23 March 2023
by Jeffrey H. Anderson

On the Third Anniversary of the First Lockdown, Help Us Convince People to Say ‘Never Again’

23 March 2023
by Toby Young

IPCC’s Increasingly Shrill Climate Armageddon Fantasies Gain Little Traction in Media

23 March 2023
by Chris Morrison

News Round-Up

52

40% of Brits Still Wearing Masks and Taking Covid Tests as Experts Call for New Mask Mandate Amid Rise in Infections

49
sheepsinmasks.jpg

Is There No Cure For Maskaholics?

33

On the Third Anniversary of the First Lockdown, Help Us Convince People to Say ‘Never Again’

31

“Next Time a Prime Minister Intends to Abridge the Liberty of Millions, They May Remember the Scenes of the Boris Trial and Pause”

36
sheepsinmasks.jpg

Is There No Cure For Maskaholics?

23 March 2023
by Jeffrey H. Anderson

When Anders Tegnell Stood Alone

23 March 2023
by Will Jones

IPCC’s Increasingly Shrill Climate Armageddon Fantasies Gain Little Traction in Media

23 March 2023
by Chris Morrison

When Will They Ever Learn?

22 March 2023
by Thorsteinn Siglaugsson

The Gary Lineker ‘Crisis’ is a Distraction From the Real Problem with the BBC

22 March 2023
by Dr David McGrogan

POSTS BY DATE

June 2021
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« May   Jul »

SOCIAL LINKS

Free Speech Union
  • Home
  • About us
  • Donate
  • Privacy Policy

Facebook

Twitter

Instagram

RSS

Subscribe to our newsletter

© Skeptics Ltd.

No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter

© Skeptics Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Please note: To be able to comment on our articles you'll need to be a registered donor

Already have an account?
Please click here to login Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
wpDiscuz
You are going to send email to

Move Comment